| rdfs:label | "Enyglid"@en |
| schema:description |
"pharmaceutical product"@en
|
|
schema:date |
"2023-11-17T13:00:14+00:00"^^xsd:dateTime |
| schema:version | 2012928298 |
| wikibase:identifiers | 1 |
| wikibase:sitelinks | 0 |
| wikibase:statements | 5 |
| p:P31 | wd:statement/Q29005808-1D3824F7-199E-460A-9668-E57456C749D4 |
| wd:statement/Q29005808-43A58FA0-6E55-430A-8567-85111CCDCC49 | |
| p:P3637 | wd:statement/Q29005808-62E90795-F20E-40D8-9DA8-95F8ED09F065 |
| p:P3781 | wd:statement/Q29005808-B7F7B1E1-A9A9-4BC0-9DAB-FB030E825FD9 |
| p:P4044 | wd:statement/Q29005808-EEF3BC3C-9C15-4660-B7DB-4124E166489D |
| wdt:P31 | mixture |
| pharmaceutical product | |
| wdt:P3637 | "EMEA/H/C/001065" |
| wdt:P3781 | repaglinide |
| wdt:P4044 | maturity-onset diabetes of the young type 2 |
Download as: